• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GLAUKOS CORPORATION ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM; AQUEOUS SHUNT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GLAUKOS CORPORATION ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM; AQUEOUS SHUNT Back to Search Results
Model Number IS3-US
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/06/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Additional information: d6: estimated implant date based on report details.The device was not available; therefore, product testing on the actual device could not be performed.The device history record review of the manufacturing lot was performed and there were no non-conformities found to be related to the reported event.A review of the device labeling was completed.Dislodged/dislocated stent is identified in the labeling as a known inherent risk of trabecular micro-bypass stent procedure.The ifu adequately provides instructions for stent implantation, precautions, and warnings for the proper use and handling of the device.An adverse event appears to have occurred but does not appear to have been a problem with the device or the way it was used.Dislodged/dislocated stent is an established risk associated with use of the device, which is clearly specified in the product's labeling.Based on the information received, the root cause of the reported event could not be conclusively identified.Mfr# reference: (b)(4).
 
Event or Problem Description
It was reported that following a right eye (od) trabecular microbypass stent system procedure, the patient presented one (1) week postoperatively with a dislodged stent resting on the iris.Per report, the dislodged stent was successfully removed from the patient's eye the following day.Additional information has been requested.
 
Additional Manufacturer Narrative
Additional information: a3, a6, b5, b6, g2, g3.Mfr# reference: (b)(4).
 
Event or Problem Description
Through follow-up, the following additional information was received.Per report, intraoperative complications were described as "hyphema" and "poor view".Reportedly, there was no adverse patient impact, and the event has resolved with the patient "doing well".The report also noted that the patient is on blood thinners.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM
Common Device Name
AQUEOUS SHUNT
Manufacturer (Section D)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer (Section G)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer Contact
brittany massey
229 avenida fabricante
san clemente, CA 92672
949367960
MDR Report Key20727624
Report Number2032546-2024-00132
Device Sequence Number8989433
Product Code KYF
UDI-Device Identifier00853704002449
UDI-Public01008537040024491031844617260228
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
K220032
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2026
Device Model NumberIS3-US
Device Lot Number318446
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/06/2024
Supplement Date Received by Manufacturer12/02/2024
Initial Report FDA Received Date11/19/2024
Supplement Report FDA Received Date12/09/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured04/12/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age81 YR
Patient SexMale
Patient RaceWhite
-
-